Advertisement

 

 

December 2017 Briefing – Rheumatology

December 2017 Briefing – Rheumatology
Advertisement

Here are what the editors at HealthDay consider to be the most important developments in Rheumatology for December 2017. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.

Tips Offered for Patient-Provider Opioid Tapering Talks

THURSDAY, Dec. 28, 2017 (HealthDay News) — Helping patients understand individualized reasons for opioid tapering and encouraging them to provide input into the process are key for patient-provider communications, according to a study published in the November issue of the Journal of Pain.

Abstract
Full Text (subscription or payment may be required)

Criteria Developed for Idiopathic Inflammatory Myopathies

THURSDAY, Dec. 28, 2017 (HealthDay News) — New classification criteria have been developed for idiopathic inflammatory myopathies (IIM), according to an article published in the December issue of Arthritis & Rheumatology.

Abstract
Full Text (subscription or payment may be required)

Rituximab Effective for Lupus-Associated Cytopenia

WEDNESDAY, Dec. 27, 2017 (HealthDay News) — Rituximab treatment seems effective for systemic lupus erythematosus (SLE)-associated immune cytopenias, with an overall initial response rate of 86 percent, according to a study published online Dec. 16 in the American Journal of Hematology.

Abstract
Full Text (subscription or payment may be required)

Rheumatic Diseases Associated With Increased Dementia Risk

WEDNESDAY, Dec. 20, 2017 (HealthDay News) — Patients with various rheumatic diseases have an increased risk of dementia, according to a study published online Dec. 15 in the International Journal of Rheumatic Diseases.

Abstract
Full Text (subscription or payment may be required)

RA Exposure In Utero Tied to Increased Disease Risk

TUESDAY, Dec. 19, 2017 (HealthDay News) — Children born to mothers with rheumatoid arthritis may have an increased risk of rheumatoid arthritis, thyroid disease, and epilepsy, according to a study published online Dec. 11 in Arthritis Care & Research.

Abstract
Full Text (subscription or payment may be required)

Male U.S. Doctors Receive Higher Values of Industry Payments

MONDAY, Dec. 18, 2017 (HealthDay News) — Male physicians in the United States received higher values of general payments from industry than females in 2015, according to a research letter published online Dec. 18 in JAMA Internal Medicine.

Abstract/Full Text

Year One Results Out for Value-Based Payment Modifier Program

MONDAY, Dec. 18, 2017 (HealthDay News) — Almost 30 percent of eligible practices failed to register and report data in the first year of the Physician Value-Based Payment Modifier program, according to a report published in the December issue of Health Affairs.

Abstract/Full Text (subscription or payment may be required)

Doctors Must Report on at Least 1 Patient, 1 Measure for MACRA

FRIDAY, Dec. 15, 2017 (HealthDay News) — In order to meet the 2017 Medicare and CHIP Reauthorization Act (MACRA) participation reporting deadline and avoid a Medicare payment penalty in 2019, physicians must report on at least one patient and one measure by Dec. 31, and submit to Medicare no later than Feb. 28, 2018, according to a report from the American Medical Association (AMA).

More Information

Making Insurers Participate in Marketplace Could Cut Volatility

THURSDAY, Dec. 14, 2017 (HealthDay News) — Requiring insurers that participate in Medicare or Medicaid to also participate in Marketplaces in the same geographic area could improve access to insurance, according to a study published in the December issue of Health Affairs.

Abstract/Full Text (subscription or payment may be required)

Allopurinol Rx More Likely With Eligibility at Diagnosis

TUESDAY, Dec. 12, 2017 (HealthDay News) — Allopurinol prescribing is more likely if patients meet eligibility criteria at diagnosis, according to a research brief published in the November/December issue of the Annals of Family Medicine.

Abstract
Full Text

Deceleration in Health Care Spending Growth in 2016

MONDAY, Dec. 11, 2017 (HealthDay News) — Health care spending growth slowed in 2016 following faster growth in 2014 and 2015, according to research published online Dec. 6 in Health Affairs.

Abstract
Full Text

CVS-Aetna Merger Has Implications for Doctors’ Offices

TUESDAY, Dec. 5, 2017 (HealthDay News) — CVS Health’s planned purchase of insurance giant Aetna, a $69 billion deal, was announced Sunday.

More Information – NYT
More Information – HealthDay

Poor Agreement for Practitioners in Defining Myofascial Pain

FRIDAY, Dec. 1, 2017 (HealthDay News) — Health care practitioner groups differ regarding the signs and symptoms that define myofascial pain syndrome (MPS), according to a study published online Nov. 1 in PAIN Practice.

Abstract
Full Text (subscription or payment may be required)

Copyright © 2018 ScoutNews, LLC. All rights reserved.
healthday

Submit a Comment

Your email address will not be published. Required fields are marked *

four + 10 =

[ HIDE/SHOW ]